Literature DB >> 9469454

CD14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS.

R L Kitchens1, R S Munford.   

Abstract

We analyzed the impact of ligand aggregation and LPS-induced signaling on CD14-dependent LPS internalization kinetics in human monocytic THP-1 cells and murine macrophages. Using two independent methods, we found that the initial rate and extent of LPS internalization increased with LPS aggregate size. In the presence of LPS binding protein (LBP), large LPS aggregates were internalized extremely rapidly (70% of the cell-associated LPS was internalized in 1 min). Smaller LPS aggregates were internalized more slowly than the larger aggregates, and LPS monomers, complexed with soluble CD14 in the absence of LBP, were internalized very slowly after binding to membrane CD14 (5% of the cell-associated LPS was internalized in 1 min). In contrast, the initial aggregation state had little or no effect on the stimulatory potency of the LPS. Previous studies suggest that LPS-induced signal responses may influence the intracellular traffic and processing of LPS. We found that elicited peritoneal macrophages from LPS-responsive (C3H/HeN) and LPS-hyporesponsive (C3H/HeJ) mice internalized LPS with similar kinetics. In addition, pre-exposure of THP-1 cells to LPS had no effect on their ability to internalize subsequently added LPS, and pre-exposure of the cells to the LPS-specific inhibitor, LA-14-PP, inhibited stimulation of the cells without inhibiting LPS internalization. In these cells, LPS is thus internalized by a constitutive cellular mechanism(s) with kinetics that depend importantly upon the physical state in which the LPS is presented to the cell.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469454

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  The internalization time course of a given lipopolysaccharide chemotype does not correspond to its activation kinetics in monocytes.

Authors:  A Lentschat; V T El-Samalouti; J Schletter; S Kusumoto; L Brade; E T Rietschel; J Gerdes; M Ernst; H Flad; A J Ulmer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  An MD2-derived peptide promotes LPS aggregation, facilitates its internalization in THP-1 cells, and inhibits LPS-induced pro-inflammatory responses.

Authors:  Anshika Tandon; Munesh Kumar Harioudh; Nayab Ishrat; Amit Kumar Tripathi; Saurabh Srivastava; Jimut Kanti Ghosh
Journal:  Cell Mol Life Sci       Date:  2018-01-08       Impact factor: 9.261

3.  Dynamics of the Fas- and stress-induced apoptosis of human neutrophils under the action of endotoxins.

Authors:  M G Vinokurov; M M Yurinskaya; A V Suslikov; V A Pechatnikov; S V Grachev
Journal:  Dokl Biol Sci       Date:  2006 Sep-Oct

4.  Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.

Authors:  Lutz Hamann; Christian Alexander; Cordula Stamme; Ulrich Zähringer; Ralf R Schumann
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance.

Authors:  Patricia A Thompson; Karine C Gauthier; Alan W Varley; Richard L Kitchens
Journal:  J Lipid Res       Date:  2010-05-15       Impact factor: 5.922

Review 6.  Virulence and immunomodulatory roles of bacterial outer membrane vesicles.

Authors:  Terri N Ellis; Meta J Kuehn
Journal:  Microbiol Mol Biol Rev       Date:  2010-03       Impact factor: 11.056

7.  Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva.

Authors:  Akiko Uehara; Shunji Sugawara; Kouichi Watanabe; Seishi Echigo; Mitsunobu Sato; Takahiro Yamaguchi; Haruhiko Takada
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

8.  Gram-positive and gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways.

Authors:  L Rabehi; T Irinopoulou; B Cholley; N Haeffner-Cavaillon; M P Carreno
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

9.  Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.

Authors:  A M O'Hara; A P Moran; R Würzner; A Orren
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

Review 10.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.